Clinical Trials Archives

Featured Partners

By Real World Health Care Editorial Staff | Sep 21, 2022

American Cancer Society Funds Pioneering Research in Acute Lymphoblastic Leukemia

September is Childhood Cancer Awareness Month, an observance recognized by health care institutions, advocacy organizations, patients and families around the world. While childhood cancer is rare, it is the leading cause of disease-related death past infancy in children and adolescents, according to the National Cancer Institute. Acute Lymphoblastic Leukemia (ALL)…more.

Categories: CAR-T Cell Therapy, Leukemia

By Real World Health Care Editorial Staff | Jul 13, 2022

Alzheimer’s Association Calls for Diversity in Clinical Trial Participation

Access to health care and the opportunity to achieve optimal health should not depend on where people live, their socioeconomic status, or their race and ethnicity, but as the COVID-19 pandemic has shown, that is not always the case. COVID-related disparities served to shine a light on other areas of…more.

Categories: Alzheimer's Disease, Health Disparities, Racial and Ethnic Disparities

By Real World Health Care Editorial Staff | Jun 15, 2022

Cancer Research Belongs in the Community

Studies have shown that cancer disproportionately impacts racial and ethnic minority groups, however, these groups remain underrepresented in cancer clinical trials.1,2,3 With unique insights into issues facing underrepresented patient populations, the Association of Community Cancer Centers (ACCC) recently developed consensus-driven recommendations to improve diversity, equity and accessibility in cancer research.…more.

Categories: Health Disparities, Racial and Ethnic Disparities

By Lecia Sequist, MD, MPH, Associate Professor of Medicine, Harvard Medical School | Sep 6, 2017

Non-Small Cell Lung Cancer: EGFR Mutations and Targeted Therapies

For the next several weeks, Real World Health Care will take a brief hiatus as we re-publish some of our most popular interviews on oncology-related topics. The editors of Real World Health Care, along with our sponsor, the HealthWell Foundation, understand that cancer takes a huge toll on patients, their…more.

Categories: General, Non-Small Cell Lung Cancer

By Lecia Sequist, MD, MPH, Associate Professor of Medicine, Harvard Medical School | Dec 7, 2016

Non-Small Cell Lung Cancer: EGFR Mutations and Targeted Therapies

Continuing our series on non-small cell lung cancer, this week Real World Health Care speaks with Lecia V. Sequist, MD, MPH, Associate Professor of Medicine at Harvard Medical School and the Mary B. Soltonstall endowed chair in oncology at Massachusetts General Hospital. Dr. Sequist’s research focuses on studying novel targets…more.

Categories: General, Non-Small Cell Lung Cancer, Personalized Medicine, Treatment Horizons

By Jennifer King, PhD, Director of Science and Research, Lung Cancer Alliance | Oct 5, 2016

Lung Cancer Alliance Moves Research Forward Through Innovative Partnerships

This week, Real World Health Care speaks with Jennifer King, Ph.D., Director of Science and Research for the Lung Cancer Alliance. The Lung Cancer Alliance is the leading and highest rated nonprofit organization dedicated to fighting lung cancer in the nation. Since 1995, it has played a critical role in…more.

Categories: General, Non-Small Cell Lung Cancer, Personalized Medicine, Treatment Horizons

By Maria Carrillo, PhD, Alzheimer's Association Chief Scientific Officer | Jun 7, 2016

Alzheimer’s Association Outlines Research Priorities & Treatment Horizons

This week, Real World Health Care brings you a conversation with Maria Carrillo, PhD, Alzheimer’s Association Chief Scientific Officer. Formed in 1980, the Alzheimer’s Association advances research to end Alzheimer’s and dementia while enhancing care for those living with the disease. Real World Health Care: According to your literature, more…more.

Categories: Alzheimer's Disease, General, Prevention/Patient-Centered Care, Treatment Horizons

By Creighton Phelps, Ph.D., acting director, Division of Neuroscience, National Institute on Aging, National Institutes of Health | May 11, 2016

National Institute on Aging Outlines Alzheimer’s Priorities

As part of our series on Alzheimer’s Disease, Real World Health Care spoke with Creighton Phelps, Ph.D., acting director, Division of Neuroscience, National Institute on Aging, National Institutes of Health. Dr. Phelps discusses the challenges facing AD researchers and how the NIA is working to overcome them. Real World Health…more.

Categories: Alzheimer's Disease, General, Treatment Horizons